Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Multiple disclosures including restructuring or layoffs and leadership change
| ItemItem | Disclosure |
|---|---|
| Item 1.01 | Entered a material definitive agreement |
| Item 2.01 | Completed an acquisition or asset sale |
| Item 2.02 | Released results of operations or financial condition |
| Item 2.03 | Created a direct financial obligation |
| Item 2.04 | Triggered acceleration of financial obligations |
| Item 2.05 | Recorded exit or disposal costs (restructuring, layoffs, closures) |
| Item 2.06 | Recorded a material impairment |
| Item 5.02 | Director or executive officer departure or appointment |
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
Aspire Biopharma Holdings, Inc. filed this because it recorded material costs from a restructuring, layoff, facility closure, or similar exit activity that investors must be told about promptly.
1 Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems , a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue ● Aspire to acquire 100% of DCS for a total cash purchase price of $30 million ● Adds an established global brand with scale in the large and growing markets driven by trends in vehicle and mobility control systems ● Acquisition significantly accelerates Aspire’s revenue, earnings growth and cash flow profi…
This filing reports Item 1.01 (entered a material definitive agreement); Item 2.01 (completed an acquisition or asset sale); Item 2.05 (recorded exit or disposal costs (restructuring, layoffs, closures)); Item 2.06 (recorded a material impairment); Item 5.02 (director or executive officer departure or appointment); Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Aspire Biopharma Holdings, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
